Provider Adoption of Pneumococcal Conjugate Vaccine and the Impact of Vaccine Shortages

Conclusions.-While provider acceptance of pneumococcal conjugate vaccine appears high, concerns about vaccine safety, cost, and availability exist, and these concerns will need to be addressed to maximize prevention of invasive pneumococcal disease in children.